An International, Double-Blind, Randomized, Multi-Center, Parallel Group, Historical-Control Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (greater than or equal to 16 to 75 Years Old) With Partial Onset Seizures With or Without Secondary Generalization.

Trial Profile

An International, Double-Blind, Randomized, Multi-Center, Parallel Group, Historical-Control Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (greater than or equal to 16 to 75 Years Old) With Partial Onset Seizures With or Without Secondary Generalization.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions; Pharmacokinetics; Registrational; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 15 Mar 2012 This trial has been completed in Belgium as reported by European Clinical Trials Database.
    • 15 Mar 2012 Planned number of patients changed from 178 to 223 as reported by European Clinical Trials Database.
    • 04 Jun 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top